Hip Arthroscopy Postoperative Opioid Demands
Launched by RUSH UNIVERSITY MEDICAL CENTER · Sep 16, 2019
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the number of opioid pills prescribed after hip surgery affects pain management. Researchers want to find out if giving fewer opioid pills, along with other medications, can still effectively manage pain for patients who undergo hip arthroscopy, a procedure used to treat conditions like femoral acetabular impingement and labral tears. Participants will be divided into two groups: one will receive a small number of opioid pills (5 Norco), while the other group will receive the usual amount (30 Norco) after their surgery.
To be eligible for this study, participants must be adults aged 18 to 80 who are having their first hip arthroscopy and have not taken any opioid medications in the six weeks before surgery. They should also be able to speak English and give written consent to join the study. If you decide to participate, you can expect to receive either a limited or standard prescription for pain relief, along with other medications to help with pain management. The trial is currently recruiting participants, and your involvement could provide valuable information about safer pain management practices after hip surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients age 18-80 years
- • English speaking
- • Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program
- • Primary hip arthroscopy
- • Written and informed consent for study participation
- Exclusion Criteria:
- • Minors (\<18 years of age)
- • Opioid tolerant patients
- • Revision surgery
- • Prior infections of the operative joint
- • History of active malignancy within the past 5 years
- • Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia
- • History of alcohol or other substance use disorder
- • Other disease states including rheumatologic conditions, diabetes mellitus, hypo/hyperthyroidism, depression, anxiety
- • Grade IV chondral defects
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials